Literature DB >> 32651186

Different rates of flux through the biosynthetic pathway for long-chain versus very-long-chain sphingolipids.

Iris D Zelnik1, Giora Volpert1, Leena E Viiri2, Dimple Kauhanen3, Tamar Arazi1, Katriina Aalto-Setälä2, Reijo Laaksonen3,4, Anthony H Futerman5.   

Abstract

The backbone of all sphingolipids (SLs) is a sphingoid long-chain base (LCB) to which a fatty acid is N-acylated. Considerable variability exists in the chain length and degree of saturation of both of these hydrophobic chains, and recent work has implicated ceramides with different LCBs and N-acyl chains in distinct biological processes; moreover, they may play different roles in disease states and possibly even act as prognostic markers. We now demonstrate that the half-life, or turnover rate, of ceramides containing diverse N-acyl chains is different. By means of a pulse-labeling protocol using stable-isotope, deuterated free fatty acids, and following their incorporation into ceramide and downstream SLs, we show that very-long-chain (VLC) ceramides containing C24:0 or C24:1 fatty acids turn over much more rapidly than long-chain (LC) ceramides containing C16:0 or C18:0 fatty acids due to the more rapid metabolism of the former into VLC sphingomyelin and VLC hexosylceramide. In contrast, d16:1 and d18:1 ceramides show similar rates of turnover, indicating that the length of the sphingoid LCB does not influence the flux of ceramides through the biosynthetic pathway. Together, these data demonstrate that the N-acyl chain length of SLs may not only affect membrane biophysical properties but also influence the rate of metabolism of SLs so as to regulate their levels and perhaps their biological functions.
Copyright © 2020 Zelnik et al.

Entities:  

Keywords:  ceramide; fatty acids; hexosylceramide; lipid metabolism; lipidomics; sphingomyelin; stable isotopes; turnover

Year:  2020        PMID: 32651186      PMCID: PMC7529049          DOI: 10.1194/jlr.RA120000984

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  28 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  Long-term performance and stability of molecular shotgun lipidomic analysis of human plasma samples.

Authors:  Laura A Heiskanen; Matti Suoniemi; Hung Xuan Ta; Kirill Tarasov; Kim Ekroos
Journal:  Anal Chem       Date:  2013-08-27       Impact factor: 6.986

3.  Ceramide is upregulated and associated with mortality in patients with chronic heart failure.

Authors:  Jingjia Yu; Wei Pan; Ruizheng Shi; Tianlun Yang; Yuanjian Li; Guolong Yu; Yongping Bai; Edward H Schuchman; Xingxuan He; Guogang Zhang
Journal:  Can J Cardiol       Date:  2014-12-11       Impact factor: 5.223

4.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

Authors:  Sarah M Turpin; Hayley T Nicholls; Diana M Willmes; Arnaud Mourier; Susanne Brodesser; Claudia M Wunderlich; Jan Mauer; Elaine Xu; Philipp Hammerschmidt; Hella S Brönneke; Aleksandra Trifunovic; Giuseppe LoSasso; F Thomas Wunderlich; Jan-Wilhelm Kornfeld; Matthias Blüher; Martin Krönke; Jens C Brüning
Journal:  Cell Metab       Date:  2014-10-07       Impact factor: 27.287

5.  Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors.

Authors:  Christian Riebeling; Jeremy C Allegood; Elaine Wang; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

6.  Determining the Turnover of Glycosphingolipid Species by Stable-Isotope Tracer Lipidomics.

Authors:  Tore Skotland; Kim Ekroos; Simona Kavaliauskiene; Jonas Bergan; Dimple Kauhanen; Tuulia Lintonen; Kirsten Sandvig
Journal:  J Mol Biol       Date:  2016-06-27       Impact factor: 5.469

Review 7.  A Stroll Down the CerS Lane.

Authors:  Iris D Zelnik; Batsheva Rozman; Eden Rosenfeld-Gur; Shifra Ben-Dor; Anthony H Futerman
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

8.  Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsy.

Authors:  Mai-Britt Mosbech; Anne S B Olsen; Ditte Neess; Oshrit Ben-David; Laura L Klitten; Jan Larsen; Anne Sabers; John Vissing; Jørgen E Nielsen; Lis Hasholt; Andres D Klein; Michael M Tsoory; Helle Hjalgrim; Niels Tommerup; Anthony H Futerman; Rikke S Møller; Nils J Færgeman
Journal:  Ann Clin Transl Neurol       Date:  2014-01-13       Impact factor: 4.511

9.  Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.

Authors:  Kirill Tarasov; Kim Ekroos; Matti Suoniemi; Dimple Kauhanen; Tuulia Sylvänne; Reini Hurme; Ioanna Gouni-Berthold; Heiner K Berthold; Marcus E Kleber; Reijo Laaksonen; Winfried März
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

10.  Ceramide Remodeling and Risk of Cardiovascular Events and Mortality.

Authors:  Linda R Peterson; Vanessa Xanthakis; Meredith S Duncan; Stefan Gross; Nele Friedrich; Henry Völzke; Stephan B Felix; Hui Jiang; Rohini Sidhu; Matthias Nauck; Xuntian Jiang; Daniel S Ory; Marcus Dörr; Ramachandran S Vasan; Jean E Schaffer
Journal:  J Am Heart Assoc       Date:  2018-05-03       Impact factor: 5.501

View more
  1 in total

1.  Lipidomics Profiles and Lipid Metabolite Biomarkers in Serum of Coal Workers' Pneumoconiosis.

Authors:  Zhangjian Chen; Jiaqi Shi; Yi Zhang; Jiahe Zhang; Shuqiang Li; Li Guan; Guang Jia
Journal:  Toxics       Date:  2022-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.